Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Satsuma Pharmaceuticals, Inc. (STSA)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 31,530,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a therapeutic product for the acute treatment of migraine. Co.'s product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. Co.'s development plan for STS101 included a completed Phase 1 trial; a Phase 3 efficacy trial (the SUMMIT trial), which is ongoing; and continuation of the open-label, Phase 3 long-term safety trial of STS101 (the ASCEND trial).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 52,530,894 59,120,894
Total Buy Value $0 $0 $47,803,114 $52,304,126
Total People Bought 0 0 2 3
Total Buy Transactions 0 0 3 6
Total Shares Sold 0 0 0 3,250,000
Total Sell Value $0 $0 $0 $2,294,500
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 74
  Page 2 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Commodore Capital Lp 10% Owner   –       –       •   2021-10-19 4 B $5.07 $444,031 I/I 87,580 3,458,535 1.5     -
   Commodore Capital Lp 10% Owner   –       –       •   2021-10-18 4 B $4.87 $176,265 I/I 36,194 3,370,955 1.5     -
   Commodore Capital Lp 10% Owner   –       –       •   2021-10-15 4 B $4.83 $608,580 I/I 126,000 3,334,761 1.5     -
   Commodore Capital Lp 10% Owner   –       –       •   2021-10-14 3 IO $0.00 $0 I/I 0 3,208,761     -
   Shah Rajeev M. Director   –       •       •   2021-02-26 4 B $5.68 $6,999,998 I/I 1,232,394 5,155,854 2.25     -
   Albrecht Detlef Chief Medical Officer   •       –      –    2020-09-01 4 AS $22.21 $22,210 D/D (1,000) 20,212     -
   Albrecht Detlef Chief Medical Officer   •       –      –    2020-09-01 4 OE $4.56 $4,560 D/D 1,000 21,212     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-09-01 4 AS $22.19 $16,645 D/D (750) 0     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-09-01 4 OE $4.56 $3,420 D/D 750 750     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-08-05 4 AS $25.00 $25,000 D/D (1,000) 0     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-08-05 4 OE $4.56 $4,560 D/D 1,000 1,000     -
   Albrecht Detlef Chief Medical Officer   •       –      –    2020-08-03 4 AS $22.85 $22,906 D/D (1,000) 20,212     -
   Albrecht Detlef Chief Medical Officer   •       –      –    2020-08-03 4 OE $4.56 $4,560 D/D 1,000 20,412     -
   Albrecht Detlef Chief Medical Officer   •       –      –    2020-07-01 4 AS $25.69 $26,683 D/D (1,000) 20,212     -
   Albrecht Detlef Chief Medical Officer   •       –      –    2020-07-01 4 OE $4.56 $4,560 D/D 1,000 20,312     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-07-01 4 AS $25.63 $26,654 D/D (1,000) 0     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-07-01 4 OE $4.56 $4,560 D/D 1,000 306     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-06-23 4 AS $35.23 $74,512 D/D (2,115) 0     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-06-23 4 OE $1.04 $2,200 D/D 2,115 2,115     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-06-01 4 AS $25.32 $25,324 D/D (1,000) 0     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-06-01 4 OE $4.56 $4,560 D/D 1,000 1,000     -
   Albrecht Detlef Chief Medical Officer   •       –      –    2020-06-01 4 AS $25.26 $25,257 D/D (1,000) 20,212     -
   Albrecht Detlef Chief Medical Officer   •       –      –    2020-06-01 4 OE $4.56 $4,560 D/D 1,000 21,212     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-05-20 4 AS $25.00 $50,000 D/D (2,000) 0     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2020-05-20 4 OE $4.56 $9,120 D/D 2,000 2,000     -
  74 Records found
  1  2  3   
  Page 2 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us